| Gene symbol | SDC1 | Synonyms | CD138, SDC, SYND1, syndecan | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | syndecan 1 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1068 |
| Trial ID | ChiCTR-ONN-17011517 |
| Disease | Multiple Myeloma |
| Altered gene | CD19|CD138 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/CD138 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | CD138 CAR T cell therapy for relapse or refractory multiple myeloma |
| Year | 2017 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort 1 | |||||||
|
|||||||